Specialty Pharmacy

Target may lead to the development of new drugs that inhibit cancer.

Top articles of the week on Specialty Pharmacy Times.

Conversational messaging tools improve healthy behavior and boost patient outcomes.

A regulatory protein that weakens the immune response to viral RNA presents a new treatment target for cancer.

Extracellular matrix receptors shield cancer cells from harsh environments.

Non-inferiority found between tenofovir disoproxil fumarate and tenofovir alafenamide regimens.

Top news of the day across the health care landscape.

Possible association found between high mercury exposure and ALS.

Individuals with MS are 3 to 6 times more likely to develop seizures.

Players in the pharmaceutical supply chain have come under scrutiny as legislators target high drug costs.

Compounds demonstrate high cancer-killing activity and low-toxicity in non-tumor cell line.

A mother’s immune response to anti-herpes simplex virus-2 may disrupt development of fetal central nervous system.

Targeted and individualized breast cancer treatment is viable.

Long-term metformin therapy associated with lower serum vitamin B12 concentration.

Children with the C9orf72 mutation are affected with these diseases at a younger age than the parent.

Medical providers with a tendency to order more tests and treatments influence how the health of a population is measured.

Top news of the day from across the health care landscape.

Adjuvant bleomycin, etoposide, and cisplatin shows promise treating testicular cancer.

Many patients with stage 1 and 2 breast cancer are administered aggressive chemotherapy.

Manufacturers say they are unable to lower the cost of some drugs due to pharmacy benefit manager involvement.

The challenges of living a normal, active life while managing multiple sclerosis.

Combination therapy may improve treatment strategies for hepatocellular carcinoma.

Scientists continue to pursue the development of an HIV cure.

New treatment approach harnesses the abilty of liver cells to burn accumulated fats.

Promise seen in targeting protein in PTEN-deficient cancer cells.

Marc O'Connor, COO and chief strategy officer for Curant Health, discusses how specialty pharmacies can demonstrate value as the use of value-based care designs increase.

Updates on the national performance benchmarks for digital mammography.

Top news of the day from across the health care landscape.